CASI Pharma (CASI) Reports Q2 Loss of $0.52
CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.52). Revenue for the quarter came in at $3.98 million.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.52). Revenue for the quarter came in at $3.98 million.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.